Wolfgang Barth

Title: Wolfgang Barth: Innovator in Medicinal Chemistry

Introduction

Wolfgang Barth is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 3 patents, Barth has focused on developing compounds that have therapeutic applications in various medical conditions.

Latest Patents

Barth's latest patents include the use of 2-alkoxyphenyl-substituted imidazotriazinones. This invention relates to the use of known 2-phenyl-substituted imidazotriazinones that possess cGMP PDE-inhibitory properties. These compounds are intended for the production of medicaments aimed at treating a range of conditions, including cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, and several ophthalmic disorders such as glaucoma. Additionally, his work addresses disorders of gastric motility, cystic fibrosis, premature labor, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus, and renal syndrome.

Career Highlights

Throughout his career, Wolfgang Barth has worked with prominent companies such as Bayer Healthcare and BASF. His experience in these organizations has allowed him to refine his expertise in medicinal chemistry and contribute to groundbreaking research.

Collaborations

Barth has collaborated with notable colleagues, including Erwin Bischoff and Helmut Haning. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Wolfgang Barth's contributions to medicinal chemistry through his innovative patents demonstrate his commitment to advancing healthcare solutions. His work continues to influence the development of new treatments for various medical conditions.